160 / 172
160
patients with early rheumatoid arthritis (the BeSt study): A
randomized, controlled trial. Arthritis Rheum 2008; 58(2
Suppl):S126-35. PMID: 18240203.
127.Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Allaart CF,
Kerstens PJ, Grillet BA, de Jager MH, et al. Patient preferences
for treatment: report from a randomized comparison of
treatment strategies in early rheumatoid arthritis (BeSt trial).
Ann Rheum Dis 2007; 66: 1227-32.
128.Svensson B, Boonen A, Albertsson K, van der Heijde D,
Keller C, Hafström I. Low-dose prednisolone in addition to the
initial disease-modifying antirheumatic drug in patients with
early active rheumatoid arthritis reduces joint destruction and
increases the remission rate: a two-year randomized trial.
Arthritis Rheum 2005;52:3360-70.
129.Kirwan JR, Hällgren R, Mielants H, Wollheim F, Bjorck E,
Persson T, et al. A randomised placebo controlled 12 week trial
of budesonide and prednisolone in rheumatoid arthritis. Ann
Rheum Dis 2004; 63: 688-95.
130.van Everdingen AA, Jacobs JW, Siewertsz Van Reesema
DR, Bijlsma JW. Low-dose prednisone therapy for patients
with early active rheumatoid arthritis: clinical efficacy, disease-
modifying properties, and side effects: a randomized, double-
blind, placebo-controlled clinical trial. Ann Intern Med 2002;
136: 1-12.
131.van Everdingen AA, Siewertsz van Reesema DR, Jacobs
JW, Bijlsma JW. Low-dose glucocorticoids in early rheumatoid
arthritis: discordant effects on bone mineral density and
fractures? Clin Exp Rheumatol 2003; 21:155-60.
132.Hansen M, Podenphant J, Florescu A, Stoltenberg M,
Borch A, Kluger E, Sørensen SF, Hansen TM. A randomised
trial of differentiated prednisolone treatment in active
rheumatoid arthritis. Clinical benefits and skeletal side effects.
Ann Rheum Dis 1999;58:713-8.